According to market analysis, the Urological Cancer Therapeutics Drugs Market is projected to grow from US$ 11.56 billion in 2025 to US$ 16.92 billion by 2034, registering a CAGR of 4.88% during 2026–2034. The market growth is driven by increasing cancer incidence rates, rising adoption of precision medicine, and the introduction of novel immunotherapies and targeted treatment options... https://www.theinsightpartners.com/reports/urological-cancer-therapeutics-drugs-market